Guidance
Recommendations for research
Recommendations for research
The guideline committee has made the following recommendations for research.
Key recommendations for research
1 Availability of PrEP
What is the effectiveness and cost effectiveness of providing pre-exposure prophylaxis (PrEP) outside sexual health services, and does this reach eligible population groups different from those who do access sexual health services?
For a short explanation of why the committee made this recommendation for research, see the rationale section on access to PrEP services.
Full details of the evidence and the committee's discussion are in evidence review G: effectiveness, cost effectiveness, acceptability and unintended consequences of PrEP for HIV.
2 Mode of PrEP delivery
What are the effectiveness, cost effectiveness, availability (eligibility status), adherence considerations, and short- and long-term adverse effects (including impact on bone density) of different modes of delivery, particularly long-acting PrEP (such as injections), including in women?
For a short explanation of why the committee made this recommendation for research, see the rationale section on prescribing PrEP.
Full details of the evidence and the committee's discussion are in evidence review G: effectiveness, cost effectiveness, acceptability and unintended consequences of PrEP for HIV.
3 Delivering effective sexual health services as part of other services
How can sexual health services best be delivered together with other services (for example, drug and alcohol services)?
For a short explanation of why the committee made this recommendation for research, see the rationale section on delivering and evaluating interventions to reduce sexually transmitted infection (STI) transmission.
Full details of the evidence and the committee's discussion are in:
4 Tailoring outreach services
How can outreach be tailored to specific groups to increase their access to sexual health services and their uptake of STI testing?
For a short explanation of why the committee made this recommendation for research, see the rationale section on meeting the needs of groups with greater sexual health or access needs.
Full details of the evidence and the committee's discussion are in:
5 Reducing stigma
What are the most effective and cost-effective methods of reducing the stigma associated with accessing sexual health services?
For a short explanation of why the committee made this recommendation for research, see the rationale and impact section on co-producing interventions to reduce STI transmission.
Full details of the evidence and the committee's discussion are in:
Other recommendations for research
Value of incentives
What incentives are effective and cost effective in increasing STI testing and diagnosis, and what, if any, are the adverse and unintended consequences?
For a short explanation of why the committee made this recommendation for research, see the rationale section on self-sampling to improve the uptake and increase the frequency of STI testing.
Full details of the evidence and the committee's discussion are in:
Vaccination course completion
What factors affect whether people complete the full course of hepatitis A and B or human papillomavirus (HPV) vaccinations and how do people think they might be encouraged to complete it?
For a short explanation of why the committee made this recommendation for research, see the rationale section on HPV and hepatitis A and B vaccination in gay, bisexual and other men who have sex with men.
Full details of the evidence and the committee's discussion are in evidence review F: increasing uptake of hepatitis A, hepatitis B and human papillomavirus (HPV) vaccinations in gay, bisexual and other men who have sex with men.
Eligibility for PrEP
What is the cost effectiveness of providing PrEP to people who do not report recent condomless sex?
For a short explanation of why the committee made this recommendation for research, see the rationale section on raising awareness of pre-exposure prophylaxis for HIV.
Full details of the evidence and the committee's discussion are in evidence review G: effectiveness, cost effectiveness, acceptability and unintended consequences of PrEP for HIV.
Remote self-sampling
Have people's attitudes to remote self-sampling and regular testing for STIs changed as a result of self-sampling for COVID‑19?
What are the effectiveness and adverse outcomes of self-sampling for people with symptoms, if remote triage (for example, phone triage) indicates that this is appropriate?
For a short explanation of why the committee made this recommendation for research, see the rationale section on self-sampling to improve the uptake and increase the frequency of STI testing.
Full details of the evidence and the committee's discussion are in:
Delivering effective sexual health services
What are the experiences of LGBT+ people in accessing STI testing services, including online?
For a short explanation of why the committee made this recommendation for research, see the rationale section on tailoring interventions to improve the uptake and increase the frequency of STI testing.
Full details of the evidence and the committee's discussion are in: